{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-113915","form_type":"8-K","ticker":"FENC","cik":"0001211583","company_name":"FENNEC PHARMACEUTICALS INC.","filed_at":"2025-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.952876+00:00","generated_at":"2026-05-16T18:22:03.476596+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Fennec Pharmaceuticals redeems all convertible notes, now debt-free","bullets":["Redeemed all remaining Petrichor convertible notes for $21.73M (principal $19.48M, accrued interest $305k, redemption fee $1.95M).","Used proceeds from underwritten public offering and private placement closed Nov 17-18, 2025.","Company has no outstanding debt after the redemption.","Notes previously bore interest at prime rate plus 4.5% (floor 3.5%) and had maturity Aug 19, 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-113915","json":"https://secwatch.observer/filing/0001104659-25-113915.json","markdown":"https://secwatch.observer/filing/0001104659-25-113915.md","text":"https://secwatch.observer/filing/0001104659-25-113915.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1211583/000110465925113915/0001104659-25-113915-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1211583/000110465925113915/tm2531627d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:22:03.476596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}